Trending
Prev Story
Next Story

Natural Cycles launches wristband to replace thermometers for its FDA-cleared birth control app

The Verge •
January 15, 2026 • 10:46 PM
• By Emma Roth
5
5 reads 0 reactions

Existing Natural Cycles users can upgrade to the band at a discount.

Natural Cycles launches wristband to replace thermometers for its FDA-cleared birth control app

The company behind the controversial app launched a wristband that tracks your temperature, heart rate, and movement while you sleep.

The company behind the controversial app launched a wristband that tracks your temperature, heart rate, and movement while you sleep.

If you buy something from a link, The Verge may earn a commission. See our ethics statement.

Natural Cycles, the company behind a controversial FDA-cleared birth control app, is replacing its thermometer with a wristband that measures skin temperature, heart rate, and movement during sleep. The newly launched wristband costs $129.99 and syncs with the Natural Cycles app, which uses an algorithm to determine a person’s “daily fertility status.”

Users can already track their fertility by pairing an Apple Watch or Oura Ring with Natural Cycles, but the wristband could be an option for users who don’t have either of these devices handy. While Natural Cycles also works with newer Samsung Galaxy smartwatches and the Galaxy Ring , it’s meant for temperature-based period and cycle tracking when used with these devices — not as a way to prevent or plan pregnancy.

The FDA cleared Natural Cycles as a form of birth control in 2018, a decision that proved controversial , as it came after 37 of 668 women seeking an abortion at a Swedish hospital reported unwanted pregnancies while using the app. (Swedish regulators said the app was not malfunctioning and that it maintained the same failure rate as advertised by Natural Cycles.) Some critics argued that the device received less scrutiny from the FDA when compared to other forms of contraception.

Natural Cycles initially offered a basal thermometer with its annual plan (or available separately for $14.50) so users could take their temperatures manually. Natural Cycles spokesperson Lauren Hanafin tells The Verge that users can continue using the thermometer if they currently have one. The FDA later gave Natural Cycles approval to collect data from third-party devices, like the Apple Watch and the Oura Ring . Hanafin says the company received authorization from the FDA to start using other temperature-tracking wearables without requiring additional approval, allowing it to launch the new wristband.

Privacy concerns related to period-tracking apps grew following the Supreme Court’s decision to overturn Roe v. Wade , but the Electronic Frontier Foundation notes that while users should review the security and privacy protections of the app they choose, they aren’t an “immediate threat” to abortion-seekers. Natural Cycles says it uses pseudonymization and encryption to conceal your information, while its band only collects data that’s “necessary.”

Natural Cycles first introduced its wristband to “select” people as part of the launch of its perimenopause feature in October. The band supports Bluetooth 5.0 LE and offers a battery life of up to 14 nights after it’s fully charged via USB-C.

The Natural Cycles Band is available for purchase for $129.99, and is also included with the company’s annual plan for $149.99. Users who already have a Natural Cycles subscription can upgrade to the band for $99.99 for a limited time.

Update, January 16th: Added Swedish regulator response.

This is the title for the native ad

This is the title for the native ad

Prev Swipe Story Next

Same Story from Other Publications

Compare how 4 other independent news outlets reported on this story.

4 Publications
ABC News Australia
3d ago
PearlBone gets FDA clearance for world's largest orthopaedic market

PearlBone gets FDA clearance for world's largest orthopaedic market

A bone graft substitute made from mother-of-pearl shells sourced off the WA's Kimberley coast receives FDA clearance in the United States. Academics say it is just one example of life-changing medical innovation from WA.

Ars Technica
1w ago
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss

FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss

The risk appears small and data is mixed, but FDA wants patients to be aware.

CNN International
1w ago
FDA warns weight loss drugs may increase risk of sudden vision loss | CNN

FDA warns weight loss drugs may increase risk of sudden vision loss | CNN

The FDA is requiring new safety warnings for popular GLP-1 weight-loss medications over a potential increased risk of a rare eye condition that can cause sudden vision loss.

CNBC World
1w ago
FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound

FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound

The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.

Related Stories

Technology
Build #2612